Abstract

Objectives The experimental study aims to demonstrate the output of a vasodilator agent application on skin prior and after a skin flap elevation and the possibility of the improvement of the flap survival rate Materials and methods The study was consisted of two groups and 28 rats were used. The experimental group concerned 28 right abdominal skin flaps that 10 days pre-surgically received iloprost cream (a prostaglandin PGI2 analogue) and 4 sub-groups of 7 each one post surgically received 2.5,5,10,20 μgr/gr of iloprost, respectively. The control group concerned 28 right abdominal skin flaps that pre surgically received white petrolatum (placebo). Laser Doppler flowmetry and dynamic analysis of circulation (radioisotope 99m Tc) were used to evaluate the flaps survival. Results The study led to highly comparable results between the study and the control group, as it turned out that the study group showed a mean value of 84.52 (47.70) PU while the control group’s result was 38.06 (14.78), respectively (laser Doppler flowmetry). Statistically insignificant was the results for the 4 sub-groups of the study group. The dynamic analysis of circulation revealed hyperaemia for the iloprost applied skin flaps. Pathological examination did not show any inflammation on study group but some vacuum cells probably related to cream phagocytosis. Conclusion The application of iloprost on skin 10 days before flap elevation plainly leads to higher rates of flap survival rates.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.